Clinical Trials Directory

Trials / Completed

CompletedNCT04699266

Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes

Clinical Investigation of the Multifocal Intraocular Lens (IOL) POD F GF in Cataracteous Eyes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Beaver-Visitec International, Inc. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

To evaluate effectiveness and safety of the POD F GF Intraocular Lens (IOL) when implanted to replace the natural lens following cataract removal

Detailed description

Since the investigational lens, like conventional IOLs, is a posterior chamber lens which is widely implanted following cataract extraction, phacoemulsification is adopted. To assess the binocular vision, the investigational lens will be bilaterally implanted. Considering the safety of the study subjects, the time of implant to the remaining eye (2nd eye) will be decided based on the results of the 1st implant.

Conditions

Interventions

TypeNameDescription
DEVICEAssigned Intervention (POD F GF)The investigational lens (POD F GF )will be implanted to both eyes in subjects with bilateral cataract. Registration of patients and the implantation of the investigational lens (POD F GF) will be conducted in consideration of securing 44 eyes in 22 subjects as the analysis subjects

Timeline

Start date
2020-11-01
Primary completion
2021-08-30
Completion
2021-08-30
First posted
2021-01-07
Last updated
2023-08-01

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04699266. Inclusion in this directory is not an endorsement.